The global electron brachytherapy market size is calculated at US$ 451.36 million in 2024, grew to US$ 494.33 million in 2025, and is projected to reach around US$ 1121.66 million by 2034. The market is expanding at a CAGR of 9.52% between 2025 and 2034.
Government awareness programs: Governments are taking initiatives to create awareness about radiotherapy. This will ensure more and more people will get access to radiotherapy.
Miniaturised X-ray sources, customised applicators for different body parts, sophisticated imaging and treatment planning software, clinical trials to prove safety and effectiveness, and patient follow-up procedures and long-term results for various cancer types, including skin and breast cancer, are all part of the research and development of electron brachytherapy.
Clinical studies for Electron Brachytherapy (EBT) include phases to examine safety and efficacy, need clearance from the Institutional Review Board (IRB), and attempt to establish evidence for new delivery technologies and applications, such as for gynaecological and skin malignancies. This study results led to regulatory clearances, which guarantee that the EBT system and its use fulfil stringent requirements for patient care and device performance prior to broad clinical use.
Providing post-treatment care, such as managing side effects and potential activity restrictions, obtaining consent, explaining the procedure, providing post-treatment instructions, including displaying a treatment information card for radiation monitoring and offering advice regarding contact with pregnant women or children, and ensuring patient comfort with sedation if necessary are all examples of patient support for electron brachytherapy.
In April 2024, according to Prof. Frank Verhaegen, chairman of Maastro's Physics Research Division, an invention like a novel brachytherapy applicator will only be valuable if radiation oncologists can utilise it in as many clinics as feasible. We have years of experience with Varian equipment and applicators, and it takes specialised knowledge to turn this concept into a commercially viable applicator that satisfies legal criteria and can be produced in large quantities.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com